Furthermore, since HIFS regulate, in part, the stable expression of PD-L1 and VEGF, inhibition of HIFS should sensitize tumor cells to treatment with anti-angiogenic and immune checkpoint inhibitors. Here, CD274 is linked to neoplasm.